Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-01-04
2011-01-04
Sheikh, Humera N (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S465000, C424S466000
Reexamination Certificate
active
07862833
ABSTRACT:
Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended for oral administration across the oral mucosa.
REFERENCES:
patent: 1262888 (1918-04-01), Westlake
patent: 1263888 (1918-04-01), Westlake
patent: 3131123 (1964-04-01), Masquelier
patent: 3577490 (1971-05-01), Welsh et al.
patent: 3888976 (1975-06-01), Mlkvy et al.
patent: 3961041 (1976-06-01), Nishimura et al.
patent: 3962417 (1976-06-01), Howell
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4147768 (1979-04-01), Schaffer et al.
patent: 4187286 (1980-02-01), Marcus
patent: 4289751 (1981-09-01), Windheuser
patent: 4443428 (1984-04-01), Oshlack et al.
patent: 4493848 (1985-01-01), LaHann et al.
patent: 4503031 (1985-03-01), Glassman
patent: 4599342 (1986-07-01), LaHann
patent: 4613497 (1986-09-01), Chavkin
patent: 4639368 (1987-01-01), Niazi et al.
patent: 4671953 (1987-06-01), Stanley et al.
patent: 4687662 (1987-08-01), Schobel
patent: 4689218 (1987-08-01), Gazzaniga et al.
patent: 4725427 (1988-02-01), Ashmead
patent: 4753792 (1988-06-01), Aberg
patent: 4756710 (1988-07-01), Bondi et al.
patent: 4853211 (1989-08-01), Kurobe et al.
patent: 4863737 (1989-09-01), Stanley et al.
patent: 4940588 (1990-07-01), Sparks
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5028411 (1991-07-01), Callingham et al.
patent: 5053396 (1991-10-01), Blass
patent: 5055306 (1991-10-01), Barry
patent: 5073374 (1991-12-01), McCarty
patent: 5102666 (1992-04-01), Acharya
patent: 5135752 (1992-08-01), Snipes
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5223264 (1993-06-01), Wehling et al.
patent: 5314904 (1994-05-01), Egidio et al.
patent: 5387420 (1995-02-01), Mitchell et al.
patent: 5445827 (1995-08-01), Fritsch et al.
patent: 5458879 (1995-10-01), Singh et al.
patent: 5464632 (1995-11-01), Cousins
patent: 5468504 (1995-11-01), Schaeffer
patent: 5501861 (1996-03-01), Makino et al.
patent: 5503846 (1996-04-01), Wehling et al.
patent: 5559096 (1996-09-01), Edwards et al.
patent: 5607697 (1997-03-01), Alkire et al.
patent: 5624687 (1997-04-01), Yano et al.
patent: 5626866 (1997-05-01), Ebert et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5656284 (1997-08-01), Balkin
patent: 5720974 (1998-02-01), Makino
patent: 5785989 (1998-07-01), Stanley et al.
patent: 5807688 (1998-09-01), Blackburn et al.
patent: 5853748 (1998-12-01), New
patent: 5900252 (1999-05-01), Calanchi et al.
patent: 5952004 (1999-09-01), Rudnic et al.
patent: 5958455 (1999-09-01), Roser et al.
patent: 5958458 (1999-09-01), Norling et al.
patent: 6034085 (2000-03-01), Joshi et al.
patent: 6068853 (2000-05-01), Giannos et al.
patent: 6071539 (2000-06-01), Robinson et al.
patent: 6106861 (2000-08-01), Cheveau
patent: 6117912 (2000-09-01), DiSanto
patent: 6129906 (2000-10-01), Steventon
patent: 6155423 (2000-12-01), Katzner et al.
patent: 6200604 (2001-03-01), Pather et al.
patent: 6242002 (2001-06-01), Tritthart et al.
patent: 6262062 (2001-07-01), Clemens
patent: 6264981 (2001-07-01), Zhang et al.
patent: 6316027 (2001-11-01), Johnson et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6326384 (2001-12-01), Whittle et al.
patent: 6350470 (2002-02-01), Pather et al.
patent: 6368625 (2002-04-01), Siebert et al.
patent: 6391335 (2002-05-01), Pather et al.
patent: 6488961 (2002-12-01), Robinson et al.
patent: 6509036 (2003-01-01), Pather et al.
patent: 6576250 (2003-06-01), Pather et al.
patent: 6641838 (2003-11-01), Pather et al.
patent: 6680071 (2004-01-01), Johnson et al.
patent: 6759059 (2004-07-01), Pettersson et al.
patent: 6761910 (2004-07-01), Pettersson et al.
patent: 6764696 (2004-07-01), Pather et al.
patent: 6974590 (2005-12-01), Pather et al.
patent: 2001/0006677 (2001-07-01), McGinity et al.
patent: 2002/0160991 (2002-10-01), Shao
patent: 2004/0213855 (2004-10-01), Pettersson et al.
patent: 2005/0037072 (2005-02-01), Pather et al.
patent: 2005/0142197 (2005-06-01), Moe et al.
patent: 2005/0142198 (2005-06-01), Moe et al.
patent: 2005/0169989 (2005-08-01), Moe et al.
patent: 2006/0292219 (2006-12-01), Pather et al.
patent: 2007/0036853 (2007-02-01), Agarwal et al.
patent: 2211586 (1996-08-01), None
patent: 2254060 (1997-01-01), None
patent: 2218370 (1997-02-01), None
patent: 0 197 504 (1986-10-01), None
patent: 0 354 973 (1990-02-01), None
patent: 0361680 (1990-04-01), None
patent: 1 062 952 (2000-12-01), None
patent: 3160 (1872-01-01), None
patent: 2307857 (1997-06-01), None
patent: 7-277959 (1995-10-01), None
patent: 36236 (1981-04-01), None
patent: 40484 (1981-12-01), None
patent: 200611697 (2006-04-01), None
patent: WO-91/04757 (1991-04-01), None
patent: 95/07701 (1995-03-01), None
patent: WO-95/27482 (1995-10-01), None
patent: WO-95/34291 (1995-12-01), None
patent: WO-99/49842 (1995-12-01), None
patent: WO-96/29993 (1996-10-01), None
patent: WO-97/17067 (1997-05-01), None
patent: WO-99/45934 (1999-09-01), None
patent: WO-00/09093 (2000-02-01), None
patent: WO-00/35418 (2000-06-01), None
patent: 00/59423 (2000-10-01), None
patent: WO-2004/067004 (2004-08-01), None
Stanley et al, “Novel Delivery Systems: Oral Transmucosal and Intranasal Transmucosal”, Journal of Pain and Sympton Management, vol. 7, No. 3, Apr. 1992, pp. 163-171.
Hessel, P.G., et al., “A Comparison of the availability of prochlorperazinc following i.m. buccal and oral administration”, International Journal of Pharmaceutics, Jun. 1, 1989, vol. 52, Issue 2, p. 159-164.
Pather et al.,“Buccal Delivery—Enhanced Buccal Delivery of Fentanyl Using the Oravescent Drug Delivery System”, Drug Delivery Tech. , vol. 1, No. 1, Oct. 2001.
James W. Conine, Special Tablets, in Pharmaceutical Dosage Forms: Tablets vol. 1, 329 (Herbert A. Lieberman et al. eds, 1989).
Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review), American Academy of Pediatrics Committee on Drugs, Pediatrics, vol. 100, No. 1 Jul. 1997, 143, 147.
Ranade, V.V.; Drug Delivery Systems Part 5B. Oral Drug Delivery, The Journal of Clinical Pharmacology, Feb. 1991, pp. 98-115, vol. 31.
Giannos, S.A.; Dinh, S.M.; Berner, B.; Temporally Controlled Drug Delivery Systems: Coupling of pH Oscillators with Membrane Diffusion, Journal of Pharmaceutical Sciences, May 1995, pp. 539-543, vol. 84, No. 5.
Amighi, K.; Timmermans, J.; Puigdevall, J.; Baltes, E.; Moës, A.. J.; Peroral Sustained-Release Film-Coated Pellets as a Means to Overcome Physicochemical and Biological Drug-Related Problems. I. In Vitro Development and Evaluation, Drug Development and Industrial Pharmacy, 1998, pp. 509-515, vol. 24, No. 6.
Sorasuchart, W.; Wardrop, J.; Ayers, J.; Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods, Drug Development and Industrial Pharmacy, 1999, pp. 1093-1098, vol. 25, No. 10.
Berko, S.; Regdon Jun, G.; Erös, I.; Influence of pH Change on Drug Release from Rectal Suppositories, Die Pharmazie, Apr. 2000, p. 324, vol. 55., Govi-Verlag Pharmazeutischer Verlag GmbH, Eschbom.
Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R.; pH-Independent Release of a Weakly Basic Drug from Water-Insoluble and -Soluble Matrix Tablets, Journal of Controlled Release, 2000, pp. 101-110, vol. 67.
Audus, K., et al, “The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies”, Pharmaceutical Research, vol. 7, No. 5, 1990, p. 435.
U.S. Appl. No. 09/661,693, filed Sep. 14, 2000.
Weinberg et al., “Sublingual absorption of selected opioid analgesics”, Clinical Pharmacology and Therapeutics, Sep. 1988, 44 (3), pp. 335-342.
Streisand et al., “Buccal absorption of fentanyl is pH-dependent in dogs”, Anesthesiology, (Mar. 1995), 82 (3), pp. 759-764.
Chen et al., “Studies on formulations of fentanyl buccal adhesive tablets”, Zhonggup Yiyao Gongye Zazhi, 1997, 28 (3), 129-131.
Supplementary European Search Report, EP 00 92 6341, Dated Nov. 23, 2005.
Cephalon Inc., an
Cima Labs Inc.
Sheikh Humera N
LandOfFree
Effervescent oral opiate dosage forms and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effervescent oral opiate dosage forms and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effervescent oral opiate dosage forms and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712134